logo
Hengrui Pharma Prices at Top End for $1.3 Billion Hong Kong Listing

Hengrui Pharma Prices at Top End for $1.3 Billion Hong Kong Listing

Bloomberg21-05-2025

Jiangsu Hengrui Pharmaceuticals Co. priced its Hong Kong stock offering at the top of the marketed range to raise HK$9.9 billion ($1.3 billion).
The Chinese drugmaker, which focuses its research on cancer and cardiovascular diseases, sold 224.5 million shares at HK$44.05 a share, according to terms of the deal seen by Bloomberg.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why the ‘TACO' Trade Is Tempting Investors Amid US-China Talks
Why the ‘TACO' Trade Is Tempting Investors Amid US-China Talks

Bloomberg

time14 minutes ago

  • Bloomberg

Why the ‘TACO' Trade Is Tempting Investors Amid US-China Talks

On May 30, US President Donald Trump accused his Chinese counterpart, President Xi Jinping, of breaking a trade truce that brought down tariffs from extreme highs in early May. Investors saw the writing on the wall: tariffs would spike again, hurting the economy. Stocks fell more than 1%. But later the same day, Trump said he'd have a conversation with Xi, and optimism – and stock prices – were restored. When the call finally happened on June 5, the S&P 500 Index again briefly surged. The early months of Trump's second term have been marked by this pattern: The president threatens to impose sky-high tariffs and stocks tumble, then he relents and markets recover. Wall Street has learned to capitalize on this by buying into the S&P 500 when it first drops, anticipating the president will backtrack on tariffs and send markets higher.

Trump Should Get The Hint That Xi Just Isn't That Into Him
Trump Should Get The Hint That Xi Just Isn't That Into Him

Forbes

time16 minutes ago

  • Forbes

Trump Should Get The Hint That Xi Just Isn't That Into Him

China's President Xi Jinping (R) and U.S. President Donald Trump. BRENDAN SMIALOWSKIFRED DUFOUR/AFP via Getty Images Xi Jinping probably doesn't know whether to be flattered or aggrieved by Donald Trump's late-night rantings about the Chinese leader. Sounding more like a jilted ex than a head of state — or a force to reckon with in negotiations — the U.S. president complained Xi is proving 'extremely hard to make a deal with.' Trump, on social media, sounded sincere enough — as if it just dawned on him that Beijing might not be interested in a bilateral trade deal after all. All this raises almost too many questions to pose here. One: Doesn't Trump recall Xi giving him the talk-to-the-hand treatment the first go around from 2017 to 2021? Another: What about Xi's energy, circa 2025, makes Trump think Xi is anxious for another go? Trump, like any wistful ex, is keeping his options open. He prefaced his 2:17 a.m. Washington-time rant with 'I like President Xi of China, always have, and always will, but…' It's time that someone on Trump's staff had the courage to tell him that perhaps the most powerful Chinese leader in many decades just isn't into him and his trade tactics. On one level, Xi can be excused for lacking the bandwidth to deal with Trump World's chaos right now. Even before the Trump 2.0 era started on January 20, Asia's biggest economy was grappling with a massive property crisis that's generating deflation. Xi's Communist Party was already facing weak domestic demand and record youth unemployment. Back in November, when Team Xi assumed Kamala Harris would be the next president, Beijing was struggling to stop the national birthrate from falling. It was mulling ways to address a rapidly ageing population. It was devising bigger social safety nets to encourage China's 1.4 billion people to save less and spend more. Pre-Trump 2.0, Beijing was in the throes of trying to reduce several trillions of dollars of local government debt. Before the latest Trump tariffs, Xi's government was working to shift its growth model away from exports and runaway investment to domestic demand-led growth. It was working to reduce the dominance of inefficient state-owned enterprises. It was endeavoring to increase the use of the yuan in global trade and finance. Team Xi is also contending with a notable increase in in-person protests. Especially factory workers getting stiffed as export growth slows. Now, Trump's tariffs, volatility in the dollar and bedlam in the U.S. Treasury market are sending intensifying headwinds China's way. So, yes, a busy time to be the leader of a giant, unbalanced economy directly in the Trumpian crossfire. And the White House thinks now is a good time to drop everything and do a hasty bilateral trade deal? Trade agreements are wildly complicated affairs in the best of times, taking several months, even years. Hence, Xi's strategy of slow-walking the process, one that's worked so far. Delaying talks is all the more rational given the decent odds U.S. courts will ultimately rule against Trump's claim that presidents have tariff powers. Trump, of course, is desperate for a trade deal, any deal, to try to convince Americans that, see, the tariffs are working. His splashy signing ceremony with London doesn't count, since the U.S. has a trade surplus with the United Kingdom. Japan hasn't been as pliant as Trump seemed to expect. And new South Korean President Lee Jae-myung is more Seoul's answer to Bernie Sanders than a kindred spirit keen to work with Trump World. Europe isn't exactly fertile ground for a win. Why would Trump be threatening 50% tariffs on the EU if concessions were forthcoming from the 550-million-person market? The U.S. Trade Representative sending reminder letters to trading partners so they don't forget about the upcoming deadline for talks is telling in itself. If White House phones were ringing with good offers, such embarrassing letters wouldn't need to be sent. Also, if Trump really believed Xi is ready to make big concessions, why would his team risk a deal by going after Chinese students with a ban on visas? China, meanwhile, knows how news this week that it may place an order for hundreds of Airbus aircraft, not Boeing, will have Trump fuming. Little about the last couple of weeks suggests these two economic giants are about to sit down for nuts-and-bolts trade negotiations in good faith. Trump's late-night post might've been his way of reminding Xi that the two men were supposed to catch up via phone this week. They did indeed talk on Thursday. But it still seems like high time Trump took the hint that Xi just isn't that into his trade deal.

How the Maker of the ‘Most Complex Machine Humans Ever Created' Is Navigating Trade Fights
How the Maker of the ‘Most Complex Machine Humans Ever Created' Is Navigating Trade Fights

New York Times

time28 minutes ago

  • New York Times

How the Maker of the ‘Most Complex Machine Humans Ever Created' Is Navigating Trade Fights

Seemingly every week, Christophe Fouquet, the chief executive of the Dutch technology company ASML, has found himself grappling with political firestorms. Last month, President Trump announced 50 percent tariffs on European goods sold to the United States, potentially raising some costs for ASML's lithography machines, which are critical for producing advanced microchips. Two days later, he paused the tariffs. Around the same time, the foreign minister of the Netherlands was in Beijing, partly to discuss lifting the rules that bar Chinese companies from buying ASML's equipment. Then this week, the Dutch government collapsed, throwing any trade talks into question. All of these events had the potential to disrupt ASML, which is the only maker of complex lithography machines that can cost as much as $400 million and be as big as a train car. The tools are so coveted by nations such as China and the United States for making cutting-edge chips that ASML has been turned into a geopolitical chess piece in trade battles, with some of its products restricted for export to certain countries. The tussling has made it an uncertain time for Mr. Fouquet, 52, a Frenchman who took over as chief executive of the $300 billion company last year. 'A large part of it is still out of our hands,' he said in a recent interview from ASML's headquarters in the small town of Veldhoven, about 80 miles south of Amsterdam. Want all of The Times? Subscribe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store